Arecor Therapeutics PLC

FRA:6UI (UK)   Ordinary Shares
€ 0.80 (-0.62%) Dec 20
At Loss
P/B:
4.19
Market Cap:
€ 31.62M ($ 32.97M)
Enterprise V:
€ 28.89M ($ 30.13M)
Volume:
-
Avg Vol (2M):
-
Trade In:

Business Description

Description
Arecor Therapeutics PLC is a focused biopharmaceutical company. The company is transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying an innovative proprietary formulation technology platform, Aresta. It is developing a portfolio of proprietary products in diabetes and other indications and working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of their therapies. Geographically, it operates in the UK, Switzerland, Germany, Italy, the Rest of Europe, the USA, and India, out of which the majority is from the UK.
Name Current Vs Industry Vs History
Cash-To-Debt 9.09
Equity-to-Asset 0.49
Debt-to-Equity 0.06
Debt-to-EBITDA -0.03
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.61
Distress
Grey
Safe
Beneish M-Score -2.66
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 8.44
9-Day RSI 13.35
14-Day RSI 20.59
6-1 Month Momentum % -33.96
12-1 Month Momentum % -57.04

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.37
Quick Ratio 1.27
Cash Ratio 0.55
Days Sales Outstanding 188.27

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.4
Shareholder Yield % -0.31

Financials (Next Earnings Date:2025-05-16 Est.)

FRA:6UI's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Arecor Therapeutics PLC Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 5.729
EPS (TTM) (€) -0.328
Beta -0.55
Volatility % 51.2
14-Day RSI 20.59
14-Day ATR (€) 0.012108
20-Day SMA (€) 0.867
12-1 Month Momentum % -57.04
52-Week Range (€) 0.725 - 2.06
Shares Outstanding (Mil) 37.76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arecor Therapeutics PLC Filings

Filing Date Document Date Form
No Filing Data

Arecor Therapeutics PLC Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Arecor Therapeutics PLC Frequently Asked Questions

What is Arecor Therapeutics PLC(FRA:6UI)'s stock price today?
The current price of FRA:6UI is €0.80. The 52 week high of FRA:6UI is €2.06 and 52 week low is €0.73.
When is next earnings date of Arecor Therapeutics PLC(FRA:6UI)?
The next earnings date of Arecor Therapeutics PLC(FRA:6UI) is 2025-05-16 Est..
Does Arecor Therapeutics PLC(FRA:6UI) pay dividends? If so, how much?
Arecor Therapeutics PLC(FRA:6UI) does not pay dividend.

Press Release

Subject Date
No Press Release